Aurinia Pharmaceuticals Sues Lotus Over Lupkynis Patent Infringement in New Jersey

Aurinia Pharmaceuticals Inc., a company specializing in kidney treatments, has commenced legal proceedings against Lotus Pharmaceutical Co. Ltd. The lawsuit, filed in a federal court in New Jersey, accuses Lotus of infringing on two patents held by Aurinia. This stems from Lotus’s attempt to market a generic version of Aurinia’s drug Lupkynis, designed for treating lupus nephritis. For a more detailed account, you can refer to the article.